India In Talks With Moderna: The US biotech giant Moderna Therapeutics has confirmed that its Covid-19 vaccine sample guarantees a 94.5% success rate in its phase 3 efficacy trials. The Indian government is apparently in talks with the company over the development of the company’s vaccine candidate.  According to a senior government official, “India is ...